<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJPed</journal-id><journal-title-group><journal-title>Open Journal of Pediatrics</journal-title></journal-title-group><issn pub-type="epub">2160-8741</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojped.2023.131017</article-id><article-id pub-id-type="publisher-id">OJPed-122651</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Neonatal Pleuropulmonary Staphylococcal Disease: A Case Report
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Fatima-Ezzahra</surname><given-names>Tahiri</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Oualid</surname><given-names>Assem</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Fatiha</surname><given-names>Bennaoui</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Nadia</surname><given-names>El Idrissi Slitine</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Nabila</surname><given-names>Soraa</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Fadl</surname><given-names>Marabih Rabou Maoulainine</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Department of Neonatal Resuscitation, University Hospital Center Mohamed VI, Marrakech, Morocco</addr-line></aff><aff id="aff2"><addr-line>Health, Childhood and Development Research Team, Faculty of Medicine, Cadi Ayyad University, Marrakech, Morocco</addr-line></aff><aff id="aff3"><addr-line>Microbiology Department, University Hospital Center Mohamed VI, Marrakech, Morocco</addr-line></aff><pub-date pub-type="epub"><day>28</day><month>12</month><year>2022</year></pub-date><volume>13</volume><issue>01</issue><fpage>138</fpage><lpage>145</lpage><history><date date-type="received"><day>8,</day>	<month>December</month>	<year>2022</year></date><date date-type="rev-recd"><day>26,</day>	<month>January</month>	<year>2023</year>	</date><date date-type="accepted"><day>29,</day>	<month>January</month>	<year>2023</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Staphylococcal pleuropulmonary disease (SPP) is the localization of pathogenic staphylococcal disease in the lung and pleura and its general haematogenic consequences. This location is not primary, but follows a primary skin or mucous infection that may go unnoticed. This is a very rare phenomenon in neonatology and in the various literature reviews. Through our observation we 
  report the clinical diagnosis of a newborn 13-day age with pleuro-pulmonary staphyloccocia point of departure cutaneous, thus the paraclinical explorations performed in our patient therapeutic management and evolutionary profile after a 3-month decline. Note that the problem of resistance of staphylococci to different antibiotics is currently a real public health problem making the choice of treatment very difficult for the clinician.
 
</p></abstract><kwd-group><kwd>Newborn</kwd><kwd> Skin Infection</kwd><kwd> Respiratory Distress</kwd><kwd> Meticillin-Resistant Staphylococcus Aureus</kwd><kwd> Excavation</kwd><kwd> Pneumothorax</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Staphylococcal pleuropulmonary is a relatively common condition in infants, rare in newborns.</p><p>Despite the progress of pediatric resuscitation measures, this pathology remains formidable in developing countries.</p><p>It is a very worrying disease because of the toxicity of staphylococcus aureus, which can lead to a serious infectious shock, its necrotizing power, which causes mechanical complications, and especially because of the resistance of staphylococcus aureus to various antibiotics [<xref ref-type="bibr" rid="scirp.122651-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.122651-ref2">2</xref>].</p><p>Staphylococcal remains a pathology exclusively of young infants, very rare in the newborn see exceptional which explains all the particularity of our observation.</p><p>Positive diagnosis and management in the new child is a real challenge for each clinician, especially since the scientific literature is of particular interest to infants and the older child.</p></sec><sec id="s2"><title>2. Objective</title><p>To report the medical observation of a newborn baby hospitalized in the neonatal intensive care unit of university hospital center MOHAMMED VI MARRA-KECH who presented a purulent cutaneous collection at the xiphoid level complicated by pleuropulmonary staphylococcus aureus with meningeal and hematogenous diffusion.</p><p>Interest: Rare entity in the neonatal period, with acute and sometimes chronic complications.</p></sec><sec id="s3"><title>3. Medical Observation</title><p>Female newborn, 13 days old, premature at 34 weeks of amenorrhea and 2 days according to the ultrasound of the first trimester, from a first-degree related marriage, with no particular pathological history in the mother.</p><p>The newborn was initially hospitalized from birth for 3 days in our department for weak sucking reflex, having received parenteral nutrition by an intravenous route taken from the right hand, reeducation of the reflex by the finger and pacifier technique, rewarming with good evolution.</p><p>The patient was readmitted 10 days after her discharge for febrile respiratory distress associated with a purulent collection at the xiphoid level with liquid content measuring 3 cm in width, warm with an inflammatory aspect, and a refusal to suckle evolving for 5 days.</p><p>On admission, the newborn was hypotonic, dehydrated, febrile at 38.5 degrees, polypneic at 67 cycles/minute with signs of respiratory struggle such as moderate intercostal and subcutaneous draught. Pulmonary auscultation did not reveal any abnormalities.</p><p>The skin recoloration time was normal, no mottling, with a refusal to suckle.</p><p>The initial biological workup noted an infectious syndrome with white blood cells 18,700/ul, neutrophilic predominance at 10,050/ul with a platelet count of 132,000/ul, a C REACTIVE PROTEIN was 132.52 mg/l.</p><p>The puncture of the xiphoid collection showed a fetid purulent aspect with isolation of Meticillin-resistant Staphylococcus aureus in the bacteriological sample and in the blood culture.</p><p>In front of the refusal of suckling a lumbar puncture with study of the cerebrospinal fluid objectifying meningitis to staphylococcus aureus resistant to the Meticillin.</p><p>The patient was treated since her admission with vancomycin and amikacin with good clinical and biological evolution.</p><p>As part of the investigation of the field, an immune deficiency assessment was performed in our patient, including HIV serology, which was negative, the dosage of lymphocyte subpopulations and complement was normal.</p><p>The initial chest X-ray showed an alveolar opacity of the right middle lobe, (<xref ref-type="fig" rid="fig1">Figure 1</xref>).</p><p>A follow-up chest X-ray performed 8 days after antibiotic therapy revealed a right cavitary image related to the excavation of the initial opacity with a minimal pneumothorax on the left, (<xref ref-type="fig" rid="fig2">Figure 2</xref>).</p><p>Chest X-ray performed after a 8-week follow-up showed clear radiological cleaning (<xref ref-type="fig" rid="fig3">Figure 3</xref>).</p><p>The evolution of our patient was favorable after 2 months, pleura-pulmonary examination was normal, disappearance of the xiphoid collection and good intake of its food ration.</p><p>The infectious check-up was negative.</p></sec><sec id="s4"><title>4. Discussion</title><p>Pleuropulmonary staphylococcal disease is still the preserve of infants, accounting for 70% of children under one year of age [<xref ref-type="bibr" rid="scirp.122651-ref3">3</xref>] - [<xref ref-type="bibr" rid="scirp.122651-ref8">8</xref>], and is a fairly rare and serious condition in newborns.</p><p>Clinical manifestations are dominated by fever and rapid onset of respiratory signs [<xref ref-type="bibr" rid="scirp.122651-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.122651-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.122651-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.122651-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.122651-ref9">9</xref>].</p><p>Digestive symptoms, on the other hand, are often silent [<xref ref-type="bibr" rid="scirp.122651-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.122651-ref6">6</xref>]; when they are studied [<xref ref-type="bibr" rid="scirp.122651-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.122651-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.122651-ref9">9</xref>], their frequency is of the order of 50%; abdominal meteorism, often significant, is the best sign.</p><p>Clinical atypia in newborns is frequent, making the diagnosis difficult and often delayed.</p><p>The rapid evolution of the respiratory disease is reflected in the admission chest X-ray, which is very suggestive of the diagnosis: existence of a pleural effusion, often discreet (simple filling of a pleural sac), bullous images or even a pyopneumothorax.</p><p>The maximum delay between the first clinical signs and the radiological signs is 3 days [<xref ref-type="bibr" rid="scirp.122651-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.122651-ref11">11</xref>].</p><p>This is explained by the pathophysiology of the disease based on contamination through a cutaneous or mucosal lesion, a bacterial proliferation occurs with a localized thrombophlebitis. This will produce a pulmonary septic metastasis in the form of a furuncle with an inflammatory crown. This one will evolve from one step to the next. Pleural involvement may be via the lymphatic route from the parenchymal focus or directly via the hematogenous route [<xref ref-type="bibr" rid="scirp.122651-ref4">4</xref>].</p><p>Bacteriological evidence is most often provided by pleural samples, with blood cultures only rarely proving positive.</p><p>The germ most responsible is the staphylococcus (Staphylococcus aureus or Staphylococcus aureus), a gram-positive, immobile cocci with a grape-like or rarely small chain-like grouping.</p><p>According to the biochemical characteristics, a distinction is made between coagulase-positive staphylococci (SCP) and coagulase-negative staphylococci (SCN).</p><p>The different constituents of staphylococcus, namely the bacterial wall, exotoxins and exoenzymes, explain the pathogenic effects of staphylococcus. Thus, the staphylococcus has toxic, necrotic, dissemination and foreign material adhesion capacities.</p><p>To facilitate the diagnosis in infants, the combination of a general condition, respiratory signs and abdominal bloating in an infant is characteristic of pleuropulmonary staphylococcal disease and requires urgent hospital care.</p><p>Once the diagnosis of pleuropulmonary staphylococcal has been made, it is necessary to look for a cutaneous or mucous membrane entry point, which may be more than one month old, or for a staphylococcal focus in the surrounding environment, such as a breast abscess, panic attack, or other.</p><p>In newborns, however, the atypical clinical presentation makes clinical diagnosis very difficult.</p><p>For pleuropulmonary staphylococcal disease of non-hospital origin, Begue reports nearly 45% of resistant staphylococci in children in Togo and Saravolatz an increase from 3% to 38% between March 1980 and September 1981 [<xref ref-type="bibr" rid="scirp.122651-ref11">11</xref>].</p><p>The antibiotic therapy generally recommended combines: a penicillin M: Oxacillin or Meticillin at a rate of 150 to 200 mg/kg/day, the former having a lower minimum inhibitory concentration and causing fewer complications [<xref ref-type="bibr" rid="scirp.122651-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.122651-ref13">13</xref>] and an aminoglycoside.</p><p>From the 1980s onwards, this phenomenon of resistance accelerated, most markedly for strains of hospital origin, with percentages varying according to the nature of the services and the pathologies encountered [<xref ref-type="bibr" rid="scirp.122651-ref14">14</xref>], but exceeding 50% of staphylococcus aureus strains in most pediatric intensive care units [<xref ref-type="bibr" rid="scirp.122651-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.122651-ref16">16</xref>], and 60% to 74% of coagulase-negative staphylococcus strains [<xref ref-type="bibr" rid="scirp.122651-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.122651-ref17">17</xref>].</p><p>In the case of meticillin-resistant staphylococci, the most consistently active antibiotics are vancomycin [<xref ref-type="bibr" rid="scirp.122651-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.122651-ref18">18</xref>] [<xref ref-type="bibr" rid="scirp.122651-ref19">19</xref>] [<xref ref-type="bibr" rid="scirp.122651-ref20">20</xref>] [<xref ref-type="bibr" rid="scirp.122651-ref21">21</xref>] and rifampicin, whose minimal inhibitory concentration appears to be very low [<xref ref-type="bibr" rid="scirp.122651-ref18">18</xref>] [<xref ref-type="bibr" rid="scirp.122651-ref21">21</xref>] [<xref ref-type="bibr" rid="scirp.122651-ref22">22</xref>] [<xref ref-type="bibr" rid="scirp.122651-ref23">23</xref>] and whose tissue penetration is satisfactory [<xref ref-type="bibr" rid="scirp.122651-ref23">23</xref>].</p><p>The choice of antibiotic therapy is in any case based on the antibiogram of the germ and the study of the bactericidal power of the different combinations.</p><p>In our patient, the treatment was based on vancomycin for a period of 4 weeks in association with amikacin for 5 days with a good clinico-biological and radiological evolution.</p><p>The usual evolution was towards a cure without sequelae with normal respiratory function tests [<xref ref-type="bibr" rid="scirp.122651-ref24">24</xref>] [<xref ref-type="bibr" rid="scirp.122651-ref25">25</xref>] [<xref ref-type="bibr" rid="scirp.122651-ref26">26</xref>] [<xref ref-type="bibr" rid="scirp.122651-ref27">27</xref>], due to the resorption capacity of pachypleuritis in children [<xref ref-type="bibr" rid="scirp.122651-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.122651-ref28">28</xref>] [<xref ref-type="bibr" rid="scirp.122651-ref29">29</xref>].</p><p>The main prognostic factors found in the literature are: young age (the disease is more severe in the first 3 months of life), [<xref ref-type="bibr" rid="scirp.122651-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.122651-ref8">8</xref>], particularly in the first month with the risk of apnea [<xref ref-type="bibr" rid="scirp.122651-ref20">20</xref>], deterioration of the general condition on admission [<xref ref-type="bibr" rid="scirp.122651-ref9">9</xref>], leukopenia [<xref ref-type="bibr" rid="scirp.122651-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.122651-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.122651-ref20">20</xref>] [<xref ref-type="bibr" rid="scirp.122651-ref30">30</xref>] more than thrombocytopenia [<xref ref-type="bibr" rid="scirp.122651-ref9">9</xref>], absence of initial effective therapy on the strain in question [<xref ref-type="bibr" rid="scirp.122651-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.122651-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.122651-ref31">31</xref>] [<xref ref-type="bibr" rid="scirp.122651-ref32">32</xref>] [<xref ref-type="bibr" rid="scirp.122651-ref33">33</xref>] [<xref ref-type="bibr" rid="scirp.122651-ref34">34</xref>].</p></sec><sec id="s5"><title>5. Conclusions</title><p>Pleuropulmonary staphylococcal disease in newborns is a rare condition with a variety of clinical and radiological presentations, and the prognosis in this age group remains poor.</p><p>The rapid increase in the percentage of meticillin-resistant strains is cause for concern, and the appropriateness of first-line antibiotic therapy with vancomycin and an aminoglycoside should be questioned.</p><p>The mortality of this disease remains high depending on the extent of the pulmonary lesions, hence the interest of an early and effective antibiotic therapy.</p></sec><sec id="s6"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s7"><title>Cite this paper</title><p>Tahiri, F.-E., Assem, O., Bennaoui, F., El Idrissi Slitine, N., Soraa, N. and Maoulainin, F.M.R. (2023) Neonatal Pleuropulmonary Staphylococcal Disease: A Case Report. Open Journal of Pediatrics, 13, 138-145. https://doi.org/10.4236/ojped.2023.131017</p></sec></body><back><ref-list><title>References</title><ref id="scirp.122651-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Qbaron, D., Drugeon, H.B. and Touze, M.D. (1987) Le Staphylocoque en 1987. Maladies Infectieuses, 37, 21.</mixed-citation></ref><ref id="scirp.122651-ref2"><label>2</label><mixed-citation publication-type="book" xlink:type="simple">Bellon, G. (1986) Pleuropulmonary Staphylococcal Disease in Infants. In: Gill, R. and Normand, J., Eds., Coord Pneumologie, Cardiologie, Paris, 21.</mixed-citation></ref><ref id="scirp.122651-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">El Mamoun, T.B. (1991) Staphylococci in Children in the Infectious Diseases Department of the Children’s Hospital of Rabat. Abdelhamid Miri, Rabat.</mixed-citation></ref><ref id="scirp.122651-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Alpert, G., Campos, J.M., Harris, M.C., Preblud, S.R. and Plotkin, S.A. (1984) Vancomycin Dosage in Pediatrics Reconsidered. American Journal of Diseases of Children, 138, 20-22. https://doi.org/10.1001/archpedi.1984.02140390012005</mixed-citation></ref><ref id="scirp.122651-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Caffey, J. (1940) Regional Obstructive Pulmonary Emphysema in Infants and in Children. American Journal of Diseases of Children, 60, 586-605.  
https://doi.org/10.1001/archpedi.1940.02000030118011</mixed-citation></ref><ref id="scirp.122651-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Jevons, M.P. (1961) “Celbenin”—Resistant Staphylococci. British Medical Journal, 1, Article No. 124. https://doi.org/10.1136/bmj.1.5219.124-a</mixed-citation></ref><ref id="scirp.122651-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Lepercq, G. and Leyne, M. (1972) Blowing during Pleuropulmonary Suppurations in Infants. Annals of Pediatrics, 19, 43-48.</mixed-citation></ref><ref id="scirp.122651-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Odio, C., McCracken Jr., G.H. and Nelson, J.D. (1984) Nephrotoxicity Associated with Vancomycln Aminoglycoside Therapy in Four Children. Journal of Pediatrics, 105, 491-493. https://doi.org/10.1016/S0022-3476(84)80036-0</mixed-citation></ref><ref id="scirp.122651-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Philips, M.R. and Milner, D.G. (1983) Clinical Pharmacology of Netilmicin in the Newborn. Archives of Disease in Childhood, 58, 451-453.  
https://doi.org/10.1136/adc.58.6.451</mixed-citation></ref><ref id="scirp.122651-ref10"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lacut</surname><given-names> J.Y. and Dupon M. </given-names></name>,<etal>et al</etal>. (<year>1982</year>)<article-title>Antibiotic Treatment of Staphylococcal Infections</article-title><source> Revue du Praticien</source><volume> 32</volume>,<fpage> 3187</fpage>-<lpage>3199</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.122651-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Pryles, C.V. (1958) Staphylococcal Pneumonia in Infancy and Childhood: An Analysis of 24 Cases. Pediatrics, 21, 609-623. https://doi.org/10.1542/peds.21.4.609</mixed-citation></ref><ref id="scirp.122651-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Chanal, M., Roussane, M.C., Miermont, C., Cluzel, M. and Sirot, D. (1980) Activité anti-bactérienne de la nétilmicine comparée avec d'autres aminosides. Médecine et Maladies Infectieuses, 10, 327-333. https://doi.org/10.1016/S0399-077X(80)80087-4</mixed-citation></ref><ref id="scirp.122651-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Chartrand, S.A. and McCracken Jr., G.H. (1982) Staphylococcal Pneumonia in Infants and Children. Pediatric Infectious Disease Journal, 1, 19-23.  
https://doi.org/10.1097/00006454-198201000-00006</mixed-citation></ref><ref id="scirp.122651-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Parker, R.H. and Fossieck Jr., B.E. (1980) Intravenous Followed by Oral Antimicrobial Therapy for Staphylococcal Endocarditis. Annals of Internal Medicine, 93, 832-834. https://doi.org/10.7326/0003-4819-93-6-832</mixed-citation></ref><ref id="scirp.122651-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Craven, D.E., Reed, C., Kollisch, N., et al. (1981) A Large Outbreak of Infections Caused by a Strain of Staphylococcus aureus Resistant to Oxacillin and Aminoglycosides. The American Journal of Medicine, 71, 53-58.  
https://doi.org/10.1016/0002-9343(81)90258-8</mixed-citation></ref><ref id="scirp.122651-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Estavoyer, J.M., Talon, D., Dupont, M.J., Bonin, P. and Michel-Briand, Y. (1984) Value of Rifampin in the Treatment of Staphylococcal Septicemia. Pathologie Biologie, 32, 552-555. (In French)</mixed-citation></ref><ref id="scirp.122651-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Estournet, B., Bataille, J. and Barois, A. (1985) Evolutiondes Infections Staphylococciques en Ranimation. Rea. Soins int. Med, 1, 53.</mixed-citation></ref><ref id="scirp.122651-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Fosse, T., et al. (1984) In Vitro Study of the Cefamandole-Fosfomycin Combination against Methicillin-Resistant Staphylococci. Pathologie Biologie, 32, 528-531. (In French)</mixed-citation></ref><ref id="scirp.122651-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Groff, D.B., Randolph, J.G. and Blades, B. (1984) Empyema in Childhood. JAMA, 195, 572-574. https://doi.org/10.1001/jama.195.7.572</mixed-citation></ref><ref id="scirp.122651-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Saint Martin, J. and Kachaner, J. (1969) Clinical Aspects and Therapeutic Possibilities of Severe Pleuropulmonary Staphylococci in Infants. Journées Parisiennes de Pédiatrie, 8, 275-299.</mixed-citation></ref><ref id="scirp.122651-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Lietman, P.S., Schaad, U.B., McCracken Jr., G.H. and Nelson, J.D. (1980) Clinical Pharmacology and Efficacy of Vancomycin in Pediatric Patients. The Journal of Pediatrics, 96, 119-126. https://doi.org/10.1016/S0022-3476(80)80347-7</mixed-citation></ref><ref id="scirp.122651-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Hendren, W.H. and Haggerty, R.J. (1958) Staphylococcal Pneumonia in Infancy and Childhood: Analysis of 75 Cases. JAMA, 168, 6-16.  
https://doi.org/10.1001/jama.1958.03000010058003</mixed-citation></ref><ref id="scirp.122651-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Henricksson, P., Svenningsen, N., Juhlin, I. and Haeger, K. (1980) Netilmicin in Moderate to Severe Infections in Newborns and Infants: A Study of Tolerance, Efficacy and Pharmacokinetics. Scandinavian Journal of Infectious Diseases, 23, 155-159.</mixed-citation></ref><ref id="scirp.122651-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Hieber, J.P., Nelson, A.J. and McCracken Jr., G.H. (1977) Acuteisseminated Staphylococcal Disease in Childhood. American Journal of Diseases of Children, 131,181-185. https://doi.org/10.1001/archpedi.1977.02120150063012</mixed-citation></ref><ref id="scirp.122651-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Jarvis, W.R., Thornsberry, C., Hughes, J.M., Boyce, J. and Haley, R.W. (1984) Methicillin-Resistant Staphylococcus aureus at Children’s Hospitals in the United States. Pediatric Research, 18, 278. 
https://doi.org/10.1203/00006450-198404001-01110</mixed-citation></ref><ref id="scirp.122651-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Sorrell, T.C. and Packham, D.R. (1982) Vancomycin therapy for Methicillin-Resistant Staphylococcus aureus. Annals of Internal Medicine, 97, 344-350. https://doi.org/10.7326/0003-4819-97-3-344</mixed-citation></ref><ref id="scirp.122651-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Kanoff, A., Kramer, B. and Carnes, M. (1939) Staphylococcus Pneumonia: A Clinical, Pathologic, and Bacteriologic Study. The Journal of Pediatrics, 14, 712-724. 
https://doi.org/10.1016/S0022-3476(39)80091-9</mixed-citation></ref><ref id="scirp.122651-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Lepercq, G., Steinschneider, R., Saada, R. and Brocard, M. (1972) Pleuropulmonary Staphylococci in Infants. Normal Initial Radiological Aspects. Annals of Pediatrics, 19, 35-41.</mixed-citation></ref><ref id="scirp.122651-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Lamberz, J., Saint Martin, J., Lallemand, D. and Huault, G. (1971) Pleuro-Pulmonary Staphylococci of Acute Evolution of the Older Child. Pliatrie, 26, 13-30.</mixed-citation></ref><ref id="scirp.122651-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Maounis, F. and Niclopoulos, D. (1969) Staphylococcal Pneumonia in Infants. Lancet, 11, 268. https://doi.org/10.1016/S0140-6736(69)90033-6</mixed-citation></ref><ref id="scirp.122651-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">McLaughlin, F.J., Goldmann, D.A., et al. (1984) Empyema in Children: Clinical Course and Long Term Follow-up. Pediatrics, 73, 587-593. 
https://doi.org/10.1542/peds.73.5.587</mixed-citation></ref><ref id="scirp.122651-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">Bingene, M.E. (1984) Introduction des dosages de traitement paramikacine desinfections sévèreset germes multiresistants chez le nourrisson et l’enfant. Société francaise de pediatrie, Editions Flammarion, Paris, 438</mixed-citation></ref><ref id="scirp.122651-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">Miser, J.S. and Miser, A.W. (1980) Staphylococcus aureus Sepsis in Childhood Malignancy. American Journal of Diseases of Children, 134, 831-833.  
https://doi.org/10.1001/archpedi.1980.02130210015005</mixed-citation></ref><ref id="scirp.122651-ref34"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">Noel, G.J. and Edelson, P.J. (1984) Staphylococcus Epidermidis Bacteremia in Neonates: Further Observations and the Occurrence of Focal Infection. Pediatrics, 74, 832-837. https://doi.org/10.1542/peds.74.5.832</mixed-citation></ref></ref-list></back></article>